title: Supervised intradialytic oral iron administration during erythropoietin therapy.
authors.forename: C
authors.initials: C
authors.lastname: Fourtounas
authors.forename: D
authors.initials: D
authors.lastname: Koutsikos
authors.forename: A
authors.initials: A
authors.lastname: Dalamangas
authors.forename: A
authors.initials: A
authors.lastname: Kapetanaki
authors.forename: M
authors.initials: M
authors.lastname: Kostoglou
authors.forename: B
authors.initials: B
authors.lastname: Agroyannis
authors.forename: H
authors.initials: H
authors.lastname: Tzanatos
authors.forename: I
authors.initials: I
authors.lastname: Kopelias
authors.forename: B
authors.initials: B
authors.lastname: Bosiolis
mesh_terms: D000284:Administration, Oral; D000368:Aged; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007501:Iron / Q000008:administration & dosage*; D000090463:Iron Deficiencies; D007676:Kidney Failure, Chronic / Q000188:drug therapy / Q000628:therapy; D008297:Male; D008875:Middle Aged; D006435:Renal Dialysis / Q000009:adverse effects*
chemical_list: D004921:Erythropoietin; D007501:Iron